[HTML][HTML] Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose …
I Takizawa, MG Lawrence, P Balanathan, R Rebello… - Oncotarget, 2015 - ncbi.nlm.nih.gov
While high doses of estrogen, in combination with androgens, can initiate prostate cancer
(PCa) via activation of the estrogen receptor α (ERα), the role of ERα in PCa cells within …
(PCa) via activation of the estrogen receptor α (ERα), the role of ERα in PCa cells within …
[HTML][HTML] Decreased expression of stromal estrogen receptor α and β in prostate cancer
G Daniels, LL Gellert, J Melamed… - American journal of …, 2014 - ncbi.nlm.nih.gov
Background: Recently there has been an increased interest in the role of tumor-associated
stroma in prostate tumorigenesis, but little is known about the respective roles of stomal ERα …
stroma in prostate tumorigenesis, but little is known about the respective roles of stomal ERα …
Prolactin‐and testosterone‐induced carboxypeptidase‐D correlates with increased nitrotyrosines and Ki67 in prostate cancer
BACKGROUND Carboxypeptidase‐D (CPD) cleaves C‐terminal arginine for conversion to
nitric oxide (NO) by nitric oxide synthase (NOS). Prolactin (PRL) and androgens stimulate …
nitric oxide (NO) by nitric oxide synthase (NOS). Prolactin (PRL) and androgens stimulate …
Profile of cell proliferation and apoptosis activated by the intrinsic and extrinsic pathways in the prostate of aging rats
ACR Gonzaga, GH Campolina‐Silva… - The …, 2017 - Wiley Online Library
BACKGROUND Estrogens acting through the receptors ERα and ERβ participate in prostate
normal growth and cancer. ERβ is highly expressed in the prostate epithelium, playing pro …
normal growth and cancer. ERβ is highly expressed in the prostate epithelium, playing pro …
Sex-based differences in the tumor microenvironment
V Wuidar, L Gillot, I Dias Da Silva, A Lebeau… - Tumor …, 2021 - Springer
Cancers are heterogeneous multifactorial diseases consisting of a major public health issue
worldwide. Sex disparities are evidenced in cancer incidence, mortality, expression of …
worldwide. Sex disparities are evidenced in cancer incidence, mortality, expression of …
Changes in estrogen receptor ERβ (ESR2) expression without changes in the estradiol levels in the prostate of aging rats
Although the prostate is androgen-dependent, it is also influenced by estrogens, which act
via the estrogen receptors ERα and ERβ. In the prostate, ERβ is highly expressed in the …
via the estrogen receptors ERα and ERβ. In the prostate, ERβ is highly expressed in the …
Carboxypeptidase‐D is elevated in prostate cancer and its anti‐apoptotic activity is abolished by combined androgen and prolactin receptor targeting
BACKGROUND Carboxypeptidase‐D (CPD) cleaves C‐terminal arginine for nitric oxide
(NO) production. CPD and NO levels are upregulated by testosterone (T) and prolactin …
(NO) production. CPD and NO levels are upregulated by testosterone (T) and prolactin …
Prostatic microenvironment in senescence: fibroblastic growth factors× hormonal imbalance
AC Hetzl, F Montico, RM Lorencini, LA Kido… - Histochemistry and cell …, 2014 - Springer
The aim was to characterize and correlate steroid hormone receptors with the FGF2, FGF7
and FGF8 reactivities in the prostatic epithelium and stroma in senile rats. Fifty male senile …
and FGF8 reactivities in the prostatic epithelium and stroma in senile rats. Fifty male senile …
Comparing the expression profiles of steroid hormone receptors and stromal cell markers in prostate cancer at different Gleason scores
T Gevaert, YR Van Eycke, T Vanden Broeck… - Scientific reports, 2018 - nature.com
The recent developments in anti-angiogenic and immunomodulatory drugs show that the
tumour micro-environment (TME) becomes increasingly important in cancer research. Here …
tumour micro-environment (TME) becomes increasingly important in cancer research. Here …
[PDF][PDF] Insight into the heterogeneity of prostate cancer through PSA-PSMA prostate clones: mechanisms and consequences
AB Jemaa, Y Bouraoui, R Oueslati - 2014 - digitum.um.es
A major clinical challenge is posed by the current inability to readily distinguish indolent from
aggressive tumors in prostate cancer patients. Research efforts are dedicated to overcome …
aggressive tumors in prostate cancer patients. Research efforts are dedicated to overcome …